Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities.

[1]  D. Antonioli,et al.  Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. , 1997, Gastroenterology.

[2]  M. Barrett,et al.  Barrett's esophagus: ordering the events that lead to cancer. , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  Carissa A. Sanchez,et al.  Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. , 1996, Oncogene.

[4]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[5]  T. Kiviluoto,et al.  Cytokeratin profile suggests metaplastic epithelial transformation in Barrett's oesophagus. , 1996, Annals of medicine.

[6]  Carissa A. Sanchez,et al.  17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Demeester,et al.  Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. , 1996, Digestive diseases.

[8]  Carissa A. Sanchez,et al.  Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. , 1996, Oncogene.

[9]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.

[10]  G. Demers,et al.  Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. , 1996, Cancer research.

[11]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[12]  M. Barrett,et al.  Genotypic analysis of multiple loci in somatic cells by whole genome amplification. , 1995, Nucleic acids research.

[13]  S. Friend,et al.  Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. , 1995, Cancer research.

[14]  K. Kohn,et al.  Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. , 1995, Cancer research.

[15]  M. Groudine,et al.  Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. , 1995, Cancer research.

[16]  Carissa A. Sanchez,et al.  A p53-dependent mouse spindle checkpoint , 1995, Science.

[17]  J. Pignon,et al.  Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. , 1995, The American journal of surgical pathology.

[18]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[19]  V. Rusch,et al.  The management of high grade dysplasia and early cancer in Barrett's esophagus , 1994, Cancer.

[20]  K. Washington,et al.  Tissue culture of epithelium derived from Barrett's oesophagus. , 1994, Gut.

[21]  Carissa A. Sanchez,et al.  p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. , 1994, Gastroenterology.

[22]  Carissa A. Sanchez,et al.  17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. , 1994, Cancer research.

[23]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[24]  B. Reid,et al.  Barrett's esophagus: a model of human neoplastic progression. , 1994, Cold Spring Harbor symposia on quantitative biology.

[25]  T. Smyrk,et al.  Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. , 1993, Endoscopy.

[26]  T. Rice,et al.  Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.

[27]  Carissa A. Sanchez,et al.  Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. , 1993, Gastroenterology.

[28]  Patricia L. Blount,et al.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.

[29]  P. Pairolero,et al.  Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. , 1993, The Annals of thoracic surgery.

[30]  C. Purdie,et al.  Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. , 1993, Oncogene.

[31]  R. Hubert,et al.  Whole genome amplification from a single cell: implications for genetic analysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Reid,et al.  Persistent clonal areas and clonal expansion in Barrett's esophagus. , 1992, Cancer research.

[33]  Brian J. Reid,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort , 1992 .

[34]  R. Sampliner,et al.  Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma. , 1992, Journal of the National Cancer Institute. Monographs.

[35]  B. Reid,et al.  Barrett's esophagus and esophageal adenocarcinoma. , 1991, Gastroenterology clinics of North America.

[36]  Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[38]  J. Trent,et al.  Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. , 1989, Cancer genetics and cytogenetics.

[39]  S. Spechler,et al.  The increasing frequency of adenocarcinoma of the esophagus , 1989, Cancer.

[40]  B. Reid,et al.  Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. , 1989, Gastroenterology.

[41]  B. Reid,et al.  Progression to cancer in Barrett's esophagus is associated with genomic instability. , 1989, Laboratory investigation; a journal of technical methods and pathology.